[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lin, 2024 - Google Patents

Cell Type-Specific FGF13 Regulation of Neuronal Function

Lin, 2024

Document ID
17955720294031417521
Author
Lin S
Publication year

External Links

Snippet

Abstract Developmental and Epileptic Encephalopathies (DEEs) are a class of devastating neurological disorders characterized by recurrent seizures, developmental delay, and cognitive impairment. DEEs are exacerbated by disruptions to excitatory/inhibitory balance …
Continue reading at search.proquest.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027New breeds of vertebrates
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases

Similar Documents

Publication Publication Date Title
Jego et al. Optogenetic identification of a rapid eye movement sleep modulatory circuit in the hypothalamus
AU2017279749B2 (en) Optogenetic control of reward-related behaviors
Sun et al. Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia
Geoffroy et al. Effects of PTEN and Nogo codeletion on corticospinal axon sprouting and regeneration in mice
Uchida et al. Learning-induced and stathmin-dependent changes in microtubule stability are critical for memory and disrupted in ageing
Terzic et al. Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder–related deficits
KR102364249B1 (en) Anti-RYK antibodies and methods of use thereof
Liu et al. Acid-sensing ion channel 1a contributes to hippocampal LTP inducibility through multiple mechanisms
Yu et al. CaMKII controls whether touch is painful
Hua et al. Partial interchangeability of Fz3 and Fz6 in tissue polarity signaling for epithelial orientation and axon growth and guidance
Kharouf et al. The hyperpolarization‐activated cyclic nucleotide‐gated 4 channel as a potential anti‐seizure drug target
Kolling et al. Modulating the excitability of olfactory output neurons affects whole-body metabolism
Ogino et al. Defects of the glycinergic synapse in zebrafish
Lin Cell Type-Specific FGF13 Regulation of Neuronal Function
Lin et al. Interneuron FGF13 regulates seizure susceptibility via a sodium channel-independent mechanism
Bandarabadi et al. Orexin action on the dopaminergic system modulates theta during REM sleep and wakefulness
Flanigan Orexin inputs to GABAergic lateral habenula neurons control aggression valence
Meza Santoscoy Analysis of the transcriptional and behavioural responses to seizure onset in a zebrafish model of epilepsy.
Martin Batista The anticonvulsant and neuroprotective roles of sgk1. 1
Chidiac Development and characterization of pain-related sodium channel mouse model for Scn10aG1663S
Astrocyte-Mediated ASNTR 2023 Abstracts
Browe Cannabinoid Modulation of Development and Neuroprotection in African Naked Mole-Rats
Terzic Temporal and Molecular Insights into the Pathophysiology of CDKL5 Deficiency Disorder
Marocha The Clustered Protocadherins in the Form and Function of Cerebellar Purkinje Cells
Landy Sensory Neurogenesis and the Role of PRDM12 in Nociceptor Development and Function